NASA Scientific and Technical Aerospace Reports

A Novel Therapeutic Vaccine for Metastatic
Mammary Carcinoma: Focusing
MHC/ Peptide Complexes to Lipid
Rafts – 174
A Research Program of Weight and Body
Composition Management for Women
with Breast Cancer – 173
A Unique Breast Cancer Cell Model for
Studying Reported Functions of
Membrane-Localized Estrogen Receptor
– 171
Analysis of the Secreted Novel Breast-
Cancer- Associated MUC1/Zs Cytokine
– 205
Angiogenesis Inhibitors in Breast Cancer
– 198
Autocine and Paracrine Control of Breast
Cancer Growth by Sex Hormone-Binding
Globulin – 223
Biochemical Analysis of the BRCA2 Protein
Complex – 200
BRCA1 Regulation of Estrogen Signaling
in the Breast – 181
Breast Cancer Research Undergraduate
Summer Training Program – 201
Cancer Immunology in an Inducible
Model of Breast Cancer – 184
Characterization of the Interactions of
BRCA1 and Protein Phosphatase
1 – 190
Cloning and Characterization of Genes
That Inhibit TRAIL-Induced Apoptosis of
Breast Cancer Cells – 221
Cloning Egr-1 Regulated Genes in
Breast Cells – 168
Cloning of a New Gene/s in Chromosome
17p3.2-p13.1 that Control Apoptosis
– 185
Cloning of Tumor Suppressor Genes in
Breast Cancer – 166
Determine the Mechanism by which Specific
ERbB Receptor Dimers Differ in
Their Ability to Disrupt Epithelial Cell Polarity
– 219
Developing a Training Program in Breast
Cancer Research to Decrease the Disparity
of Morbidity and Mortality in
Underserved/Minority Women – 206
Development of a Novel In-Situ Telomere
Length Qualification System to Address
Suitability of Telomerase Inhibitor
Therapy to Breast Cancer – 222
Development of a Transgenic Mouse
Model for Breast Cancer that is Optimized
for the Study of T Cell-Based
Therapeutic Strategies – 172
Development, Optimization, and Evaluation
of CAD System for Breast Cancer
– 197
Dietary Seaweed and Early Breast Cancer:
A Randomized Trial – 176
Effects of CSK Homologous Kinase
Overexpression on HER2/Neu-Mediated
Signal Transduction Pathways in Breast
Cancer Cells – 183
Effects of Herstatin an Alternative Her-2
(erbB-2) Product on Hormonal Responsiveness
of Breast Cancer – 195
EGF Regulation of Nuclear Co-Activator
AIB1 Function in Breast Cancer – 198
Endothelial Cell-Targeted Adenoviral
Vector for Suppressing Breast Malignancies
– 171
Endothelial Genes – 193
Estrogen and Retinoid Regulation of
DNA Repair in Breast Cancer – 191
Estrogen Receptor Inhibition of NF-
(kappa) B Activity in Breast Cancer
– 177
Evaluation of Intracavitary Chemotherapy
Delivery for the Treatment of
Mammary Carcinoma – 170
Exploring a Link Between NF-kappaB
and G2/M Cell Cycle Arrest in Breast
Cancer Cells – 191
Functional Characterization of the Murine
Homologue of PLAB a Novel TGF-B
Member in Placental and Mammary Tissues
– 169
Genetic Counseling for Breast Cancer
Susceptibility in African American
Women – 200
Genetic Determinants of Inflammatory
Breast Cancer – 198
Hormone Receptors in Breast Cancer
Prognosis - Racial and Quantitative Effects
– 221
How Does Nuclear Organization Maintain
Normal Mammary Phenotype?
– 212
Identification of Cellular Binding Sites for
a Novel Human Anti-Breast Cancer Peptide
– 196
Identification of Novel Genes Affected by
Gamma Irradiation Using a Gene-
Trapped Library of Human Mammary
Epithelial Cells – 213
IKK and (Beta)-Catenin in Breast Cancer
– 214
Immunotherapy of Breast Cancer Using
Novel Her2/neu-Based Vaccines – 189
Improving Symptoms Control QOL and
Quality of Care for Women with Breast
Cancer: Developing a Research Program
on Neurological Effects via Doctoral
Education – 208
Inactivation of FGF Receptors by Targeting
Ribozymes Against FGFR mRNAs
and Their Effect on FGF Dependent In
Vitro and In Vivo Breast Cancer Growth
Phenotypes – 222
Inhibition of Breast Cancer-Induced Angiogenesis
by a Diverged Homeobox
Gene – 215
Inhibition of Her2 Transcription by Small
Organic Molecules – 194
Interaction Between Estrogen Receptor
Beta and the Transforming Growth Factor
Beta Signaling Cascade in Human
Breast Tissue – 217
Investigating the Role of Celecoxib as a
Chemopreventive and Chemotherapeutic
Agent for Breast Cancer – 173
Investigation of Alpha6 Integrins and
Their Signaling Intermediates as Prognostic
Markers for Breast Cancer – 195
Investigation of Novel Human CED-4 Homolog
NAC-X in Apoptosis Regulation of
Breast Cancer – 208
Is Peripheral Benzodiazepine Receptor
(PBR) Gene Expression Involved in
Breast Cancer Suppression by Dietary
Soybean Protein – 222
Markers of Increased Risk in Pre-
Invasive Breast Cancer – 215
Mechanism of FADD-DN-Induced Apoptosis
in Normal Breast Cells – 188
Mechanism of Regression of c-MYC-
Induced Mammary Tumors in a Conditional
Transgenic Model – 169
Model and Expansion Based Methods of
Detection of Small Masses in Radiographs
of Dense Breasts – 168
Molecular Dissection of the 8 Phase
Transcriptional Program Controlled by
Cyclin E/P220 NPAT Signaling Pathway
– 194
Nanoparticle-Mediated p53 Gene
Therapy for Breast Cancer – 182
Novel Angiogenic Domains: Use in Identifying
Unique Transforming and Tumor
Promoting Pathways in Human Breast
Cancer – 180
Novel Magnetic Fluids for Breast Cancer
Therapy – 184
Novel MHC Class II Breast Cancer Vaccine
Using RNA Interference (RNAi) to
Down-Regulate Invariant Chain
(Ii) – 207
Omega-3 Fatty Acids and a Novel Mammary
Derived Growth Inhibitor Fatty Acid
Binding Protein MRG in Suppression of
Mammary Tumor – 173
P202 AS A Potential Therapeutic Gene
for Breast Cancer – 167
Population Based Assessment of MHC
Class I Antigens Down Regulation as
Markers of Increased Risk for Development
and Progression of Breast Cancer
From Benign Breast Lesions – 199
Regulation of Cell Cycle by BCCIP a
BRCA2 and CDKN1(p21) Interacting
Protein – 182
Regulation of ErbB-2 Metabolic Stability
– 221
Regulation of the Activity of AIB1 an
Estrogen Receptor Coactivator by
Growth Factor Signals – 215
A-41